Rosos, Joshua G.
HRN: 08-09-83 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/13/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/13/2023
06/19/2023
IV DRIP
500 Mg
Q8
Infected Urachal Cyst
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes